Cargando…

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households

BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential. METHODOLOGY/PRINCIPAL FINDINGS: As part of the Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Ssemanda, Elizabeth N., Munoz, Beatriz, Harding-Esch, Emma M., Edwards, Tansy, Mkocha, Harran, Bailey, Robin L., Sillah, Ansumana, Stare, Dianne, Mabey, David C. W., West, Sheila K.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950137/
https://www.ncbi.nlm.nih.gov/pubmed/20957196
http://dx.doi.org/10.1371/journal.pntd.0000838
_version_ 1782187628428263424
author Ssemanda, Elizabeth N.
Munoz, Beatriz
Harding-Esch, Emma M.
Edwards, Tansy
Mkocha, Harran
Bailey, Robin L.
Sillah, Ansumana
Stare, Dianne
Mabey, David C. W.
West, Sheila K.
author_facet Ssemanda, Elizabeth N.
Munoz, Beatriz
Harding-Esch, Emma M.
Edwards, Tansy
Mkocha, Harran
Bailey, Robin L.
Sillah, Ansumana
Stare, Dianne
Mabey, David C. W.
West, Sheila K.
author_sort Ssemanda, Elizabeth N.
collection PubMed
description BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential. METHODOLOGY/PRINCIPAL FINDINGS: As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82–100% and 62–99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74–0.81) and for The Gambia was 0.55 (95% CI 0.51–0.59). CONCLUSIONS/SIGNIFICANCE: In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random.
format Text
id pubmed-2950137
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29501372010-10-18 Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households Ssemanda, Elizabeth N. Munoz, Beatriz Harding-Esch, Emma M. Edwards, Tansy Mkocha, Harran Bailey, Robin L. Sillah, Ansumana Stare, Dianne Mabey, David C. W. West, Sheila K. PLoS Negl Trop Dis Research Article BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential. METHODOLOGY/PRINCIPAL FINDINGS: As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82–100% and 62–99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74–0.81) and for The Gambia was 0.55 (95% CI 0.51–0.59). CONCLUSIONS/SIGNIFICANCE: In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random. Public Library of Science 2010-10-05 /pmc/articles/PMC2950137/ /pubmed/20957196 http://dx.doi.org/10.1371/journal.pntd.0000838 Text en Ssemanda et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ssemanda, Elizabeth N.
Munoz, Beatriz
Harding-Esch, Emma M.
Edwards, Tansy
Mkocha, Harran
Bailey, Robin L.
Sillah, Ansumana
Stare, Dianne
Mabey, David C. W.
West, Sheila K.
Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title_full Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title_fullStr Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title_full_unstemmed Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title_short Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
title_sort mass treatment with azithromycin for trachoma control: participation clusters in households
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950137/
https://www.ncbi.nlm.nih.gov/pubmed/20957196
http://dx.doi.org/10.1371/journal.pntd.0000838
work_keys_str_mv AT ssemandaelizabethn masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT munozbeatriz masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT hardingeschemmam masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT edwardstansy masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT mkochaharran masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT baileyrobinl masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT sillahansumana masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT staredianne masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT mabeydavidcw masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT westsheilak masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds